Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Corcept Therapeutics Inc shares valued at $155,342 were sold by Swisher Daniel N JR on Jun 10 ’25. At $70.61 per share, Swisher Daniel N JR sold 2,200 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Guyer William sold 20,000 shares, netting a total of over 1,448,475 in proceeds. Following the sale of shares at $72.42 each, the insider now holds 5,487 shares.
Before that, Swisher Daniel N JR had added 2,200 shares to its account. In a trade valued at $155,342, the Director bought Corcept Therapeutics Inc shares for $70.61 each.
As published in a research note from Truist on November 06, 2023, Corcept Therapeutics Inc [CORT] has been rated up from a Hold to a Buy and the price target has been revised to $38 from $29. Analysts at SVB Securities started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid April. As of April 04, 2023, Piper Sandler has initiated its “an Overweight” rating for CORT. Earlier on February 15, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for CORT stock which previously was a “a Buy”.
Analyzing CORT Stock Performance
During the last five days, there has been a surge of approximately 3.14%. Over the course of the year, Corcept Therapeutics Inc shares have jumped approximately 41.26%. Shares of the company reached a 52-week high of $117.33 on 03/31/25 and a 52-week low of $49.00 on 01/13/25.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
According to the 24-hour chart, there is a support level at 69.93, which, if violated, would cause prices to drop to 68.69. In the upper region, resistance lies at 72.22. The next price resistance is at 73.26. RSI (Relative Strength Index) is 47.20 on the 14-day chart, showing neutral technical sentiment.
